Cost–utility of inhaled corticosteroids in patients with moderate-to-severe asthma

Marchetti, Monia; Cavallo, Maria Caterina; Annoni, E.; Gerzeli, Simone

doi:10.1586/14737167.4.5.549

Cited by 3 publications

(4 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A total of 15 226,[252][253][254][255][256][257][258][259][260][261][262][263][264][265] published full-text studies were judged as full economic evaluations and met our inclusion criteria and involved adults with asthma. All of the 15 studies were published after 1994.…”

Section: Summary Of the Included Cost-effectiveness Studiesmentioning

confidence: 99%

“…As Tables 69 and 70 show, of the 15 included studies, four 253,260,264,265 compared ICS monotherapies with each other, and the rest compared ICS plus a LABA with the same ICS as monotherapy. There were also two other studies, by Stempel and colleagues 266 and Barnes and colleagues, 267 which compared FP with BUD, which were excluded because they mixed effectiveness evidence from both children and adults with asthma, and did not report the results for adults separately.…”

Section: Study Types and Settingsmentioning

confidence: 99%

“…252,258,262 Of the 15 economic evaluations, 12 were CEAs, one 260 was a CUA, one 265 was a cost-minimisation analysis (CMA) and one 254 contained both CEA and CUA results. Some of the CEAs reported costeffectiveness ratios for more than one outcome measure.…”

Section: Study Types and Settingsmentioning

confidence: 99%

“…Discounting was applied only in one study (and for utility only 260 ). Most of the studies were funded by pharmaceutical companies; some also involved co-authors employed by such companies.…”

Section: Study Types and Settingsmentioning

confidence: 99%

See 3 more Smart Citations

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over

Shepherd¹,

Rogers²,

Anderson³

et al. 2008

Health Technol Assess

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) Programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as royal colleges and NHS trusts. These sugges...

show abstract